LIC trims stake in Dr Reddy’s Laboratories to 6.31%

23 Jan 2013 Evaluate

The country’s largest life insurer, Life Insurance Corporation (LIC) has trimmed its stake in drug firm Dr Reddy’s Laboratories to 6.31%. The insurer has sold shares worth Rs 875.29 crore in the open market.

LIC held 8.38% stake in the pharma major before offloading about 35.25 lakh shares, accounting for around 2.07% shareholding. Following the transaction, LIC’s total shareholding in the company has come down to 6.31% from 8.38%.

Dr Reddy's is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.

Dr. Reddys Lab Share Price

1250.40 -20.65 (-1.62%)
01-Jan-2026 13:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.00
Dr. Reddys Lab 1250.40
Cipla 1501.10
Zydus Lifesciences 912.00
Lupin 2100.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×